Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA
Open Access
- 29 May 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 36 (12) , 3926-3938
- https://doi.org/10.1093/nar/gkn313
Abstract
The selective degradation of mutated mitochondrial DNA (mtDNA) molecules is a potential strategy to re-populate cells with wild-type (wt) mtDNA molecules and thereby alleviate the defective mitochondrial function that underlies mtDNA diseases. Zinc finger nucleases (ZFNs), which are nucleases conjugated to a zinc-finger peptide (ZFP) engineered to bind a specific DNA sequence, could be useful for the selective degradation of particular mtDNA sequences. Typically, pairs of complementary ZFNs are used that heterodimerize on the target DNA sequence; however, conventional ZFNs were ineffective in our system. To overcome this, we created single-chain ZFNs by conjugating two FokI nuclease domains, connected by a flexible linker, to a ZFP with an N-terminal mitochondrial targeting sequence. Here we show that these ZFNs are efficiently transported into mitochondria in cells and bind mtDNA in a sequence-specific manner discriminating between two 12-bp long sequences that differ by a single base pair. Due to their selective binding they cleave dsDNA at predicted sites adjacent to the mutation. When expressed in heteroplasmic cells containing a mixture of mutated and wt mtDNA these ZFNs selectively degrade mutated mtDNA, thereby increasing the proportion of wt mtDNA molecules in the cell. Therefore, mitochondria-targeted single-chain ZFNs are a promising candidate approach for the treatment of mtDNA diseases.Keywords
This publication has 30 references indexed in Scilit:
- Custom-designed zinc finger nucleases: What is next?Cellular and Molecular Life Sciences, 2007
- An improved zinc-finger nuclease architecture for highly specific genome editingNature Biotechnology, 2007
- Modulating mtDNA heteroplasmy by mitochondria-targeted restriction endonucleases in a ‘differential multiple cleavage-site’ modelGene Therapy, 2007
- Targeted gene addition into a specified location in the human genome using designed zinc finger nucleasesProceedings of the National Academy of Sciences, 2007
- Sequence-specific modification of mitochondrial DNA using a chimeric zinc finger methylaseProceedings of the National Academy of Sciences, 2006
- Designer zinc-finger proteins and their applicationsGene, 2005
- Composition and Dynamics of Human Mitochondrial NucleoidsMolecular Biology of the Cell, 2003
- Gene Therapy for Mitochondrial Disease by Delivering Restriction Endonuclease SmaI into MitochondriaJournal of Biomedical Science, 2002
- Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonucleaseHuman Molecular Genetics, 2001
- DNA-induced α-helix capping in conserved linker sequences is a determinant of binding affinity in Cys2-His2 zinc fingersJournal of Molecular Biology, 2000